AOD-9604
Anti-Obesity Drug 9604 (hGH Fragment 176-191)
A modified fragment of the hGH molecule (residues 176-191) studied for lipolytic effects without impacting IGF-1 or glucose metabolism.
The research profile.
A modified fragment of the hGH molecule (residues 176-191) studied for lipolytic effects without impacting IGF-1 or glucose metabolism.
For research purposes only. Not for human consumption, diagnosis, treatment, or prevention of any condition.
Categorised as Metabolic — GLP-1s, lipolytics, and visceral-fat peptides.
Independently verified purity.
Every batch is tested by Janoshik Analytical and the Brown Institute of Biomolecular Research. The full HPLC and mass-spec report is included in the physical shipment.
- Batch
- 26076
- Purity
- 98.0%
Verified by Brown Institute of Biomolecular Research. Scan the full report for every measurement.